AxoGen Company

Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.

Headquarters: United States
Industry: Genomic and Epigenominc Instabillity
Estimated Revenue: $10M to $50M
Investors Number: 8
Technology: Other
Last Funding Type: Series G
Total Funding: $515.5M